RIGL Rigel Pharmaceuticals Inc Year-over-year net earnings per share growth for the last 12 months
Rigel Pharmaceuticals (RIGL) is integrating ESG standards and bioethics into the development of hematological drugs. The current quarterly EPS growth rate confirms this trajectory, with -55.20 serving as the current metric level. Synergy among immunology experts supports the advancement of rare medical fields, which, as part of an operational pivot, facilitates the commercial scaling of the portfolio and the company's transition to stable profitability.
Rigel Corp (RIGL) - metric breakdowns and financial figures
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Debt to Equity Rigel Pharmaceuticals|RIGL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Rigel Pharmaceuticals|RIGL - Company Total Debt Obligations|Debts to Book Capitalization Rigel Pharmaceuticals Inc|RIGL - Long-Term Indebtedness|Company Short-Term Debts Rigel Pharmaceuticals|Quick Liquidity rigel.com
- earnings and market multiples details:
RIGL - Company Net Income|Future Profit Rigel Pharmaceuticals|RIGL - Company Value to Net Income|Future Price to Earnings Rigel Pharmaceuticals Inc|RIGL - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Rigel Pharmaceuticals Inc|RIGL - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Rigel Pharmaceuticals|RIGL - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months rigel.com|RIGL - Earnings per share increase in current year|Net earnings per share growth forecast for next year Rigel Pharmaceuticals
- company sales and revenue statistics:
Analysis of all company metrics:Rigel Pharmaceuticals, Inc. - RIGL
Professional investors select resilient assets by analyzing net profit per share dynamics. This metric measures the percentage change in EPS between the current and previous quarters, determining the business scaling rate. Tracking quarterly EPS growth on the GURU.Markets platform allows for the timely detection of abnormal yield spikes. For Rigel Pharmaceuticals (RIGL), this indicator reflects the commercial success of approved hematological drugs. Stable growth confirms the efficacy of the therapy and the expansion of the company's market share.
Competitors of Rigel Pharmaceuticals
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|ADPT - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months CLDX (Celldex Corp)|AUPH: Quarterly EPS earnings growth|BCRX - Year-over-year net earnings per share change for the last twelve months|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|DNTH - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth PHVS|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|precigen.com - Year-over-year earnings per share growth for the last twelve months|PHAR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics Inc)|Upstream Bio Corp (UPB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ZBIO (Zenas Corp)|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth KALV|Quarterly EPS earnings growth Septerna, Inc. (SEPN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals Inc PVLA|Year-over-year earnings per one share growth for the last 12 months SVRA|ANAB - Year-over-year earnings per share growth for the last twelve months|astriatx.com (ATXS) - Year-over-year net earnings per share growth for the last 12 months|ENGN: Quarterly EPS earnings growth|rapt.com (RAPT) - Quarterly EPS earnings growth|JBIO (Aerovate Therapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Aclaris Therapeutics, Inc (ACRS)|Quarterly EPS earnings growth KYTX|TLSA - Earnings per share growth in annualized terms for the last twelve months|Cabaletta Bio - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Ventyx Biosciences Inc. VTYX|THTX: Year-over-year net earnings per share growth for the last 12 months|Avalo Therapeutics Inc - Year-over-year earnings per share growth rate for the last twelve months|ELDN: Quarterly EPS earnings growth|AGEN - Year-over-year net earnings per share change for the last twelve months|CLYM (Climb Bio) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months zurabio.com (ZURA)|Quarterly EPS earnings growth ATYR|Quarterly EPS earnings growth adagene.com (ADAG)|Year-over-year earnings per share growth for the last twelve months Ikena Oncology IMA|Shattuck Labs Inc - Year-over-year earnings per share growth for the last twelve months|EQ - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Connect Biopharma CNTB|immunic-therapeutics.com (IMUX) - Year-over-year earnings per share growth for the last twelve months|Atara Bio - Year-over-year earnings per one share growth for the last 12 months|IFRX (InflaRx NV) - Quarterly EPS earnings growth|x4pharma.com (XFOR) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ACET|celularity.com (CELU) - Net earnings per share growth for the trailing year|Year-over-year earnings per share growth for the last twelve months INmune Bio Corp INMB|Barinthus Biotherapeutics Corp - Year-over-year earnings per share growth for the last twelve months|KZR - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months SABS|AKTX: Quarterly EPS earnings growth|Enlivex Therapeutics Ltd. - Year-over-year earnings per one share growth for the last 12 months|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth GeoVax Corp|Year-over-year earnings per share growth for the last twelve months Edesa Biotech, Inc. (EDSA)|IBIO (ibioinc.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Carisma Therapeutics Inc. CARM|XTLB - Year-over-year net earnings per share growth for the last 12 months|Bolt Bio - Quarterly EPS earnings growth|HCWB - Quarterly EPS earnings growth|APVO (aptevotherapeutics.com) - Year-over-year net earnings per share growth for the last 12 months|aimimmuno.com - Year-over-year earnings per one share growth for the last 12 months|ADTX (Aditxt Inc.) - Quarterly EPS earnings growth|GRI Bio Inc (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Year-over-year net earnings per share growth for the last 12 months Vyome Therapeutics HIND|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI - Quarterly EPS earnings growth|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ALLK|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months IGM Bio IGMS|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA (Ocean Biomedical Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TCBP (TC BioPharm (Holdings) PLC)|Year-over-year net earnings per share change for the last twelve months Third Harmonic Bio Inc (THRD)
